Search research articles
Contact Us
Filters
Showing results (461-470 of 495) with videos related to
Page
of 50
Sort By:
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Diagnostics (Basel, Switzerland)
|
October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors
Florian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
Katharina Möller, Madeleine Knöll, Elena Bady, et al.
Biomedicines
|
December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry
Tim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
International Urology and Nephrology
|
October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder
Krystian Kaczmarek, Henning Plage, Kira Furlano, et al.
Plos One
|
July 21, 2022
High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Archives of Pathology & Laboratory Medicine
|
March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue
Maximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
The Journal of Pathology. Clinical Research
|
December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
Natalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Cancers
|
July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities
Anne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology
|
January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas
Maximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
Page
of 50
Search research articles
Search
Showing results (461-470 of 495) with videos related to
Sort By:
Page
of 50
Plos One
|
April 2, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors
Seyma Büyücek, Florian Viehweger, Viktor Reiswich, et al.
Diagnostics (Basel, Switzerland)
|
October 16, 2024
Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors
Florian Lutz, Soo-Young Han, Seyma Büyücek, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples
Katharina Möller, Madeleine Knöll, Elena Bady, et al.
Biomedicines
|
December 23, 2023
Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry
Tim Mandelkow, Elena Bady, Magalie C J Lurati, et al.
International Urology and Nephrology
|
October 1, 2023
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder
Krystian Kaczmarek, Henning Plage, Kira Furlano, et al.
Plos One
|
July 21, 2022
High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Archives of Pathology & Laboratory Medicine
|
March 14, 2024
Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue
Maximilian Lennartz, Daniela Amezada, Doris Höflmayer, et al.
The Journal of Pathology. Clinical Research
|
December 13, 2024
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
Natalia Gorbokon, Niklas Wößner, Viktoria Ahlburg, et al.
Cancers
|
July 13, 2024
Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities
Anne Menz, Julia Zerneke, Florian Viehweger, et al.
The American Journal of Surgical Pathology
|
January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas
Maximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
Page
of 50